GlassScriptPhysician profile
Reza Kermani
NPI 1295998300
$7,122.90
in general payments reported to CMS, 2019-2025
19 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,886 · 2020: $330 · 2021: $288 · 2022: $277 · 2023: $181 · 2024: $2,057 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,186 · Food and Beverage: $1,108 · Gift: $47.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,186.28 |
| Food and Beverage | $1,108.36 |
| Gift | $47.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,686.23 | 2019-2025 | Da Vinci Surgical System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.51 | 2025 | Lifevest |
| Davol INC. | $193.60 | 2019-2023 | Phasix Mesh |
| Haemonetics Corporation | $185.17 | 2025 | Teg Manager, Teg6s Hemostasis System |
| Medtronic, INC. | $142.33 | 2021-2022 | |
| Integra Lifesciences Corporation | $135.28 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acell, INC. | $82.56 | 2020 | |
| Ethicon US, LLC | $71.14 | 2021-2022 | |
| Boston Scientific Corporation | $60.32 | 2022-2024 | Spyglass Discover |
| W. L. Gore & Associates, INC. | $53.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $48.18 | 2019 | |
| Prytime Medical Devices, INC. | $42.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.57 | 2022 | |
| Prescient Surgical | $29.25 | 2020 | |
| Solventum Corporation | $27.56 | 2025 | V.A.C.Ulta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $24.87 | 2023 | Xperience, Blastx, Surgx |
| Amgen INC. | $22.92 | 2024 | Repatha |
| Aroa Biosurgery Incorporated | $19.94 | 2023 | |
| Becton, Dickinson and Company | $18.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Kermani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.